Representative batches? [Regulatives / Guidelines]

posted by Dr_Dan  – Germany, 2010-08-05 08:58 (4343 d 07:19 ago) – Posting: # 5724
Views: 14,363

Dear ElMaestro, dear Helmut and all who contribute to this fruitful discussion

» I changed the category; doesn’t look as a statistical issue to me (any more).

You are right Helmut, I made the same experience, at the beginning it looks like a statistical problem but in the course of discussion it turned out that it becomes more and more a regulatory issue. But can you argue with the assessor without statistics?

As other sponsors we selected T & R batches which matched closely. Comparative dissolution profiles showed similarity and the assay content differed less than 5%.
From the quality point of view we see no difference between the batches.

The logic consequence would be that for the release of any batch you produce for the market you have to perform a BE study as quality control.

I am still at a loss.

Kind regards

Dan

Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
22,170 posts in 4,645 threads, 1,570 registered users;
online 22 (1 registered, 21 guests [including 10 identified bots]).
Forum time: Sunday 16:18 CEST (Europe/Vienna)

The person interested in success has to learn
to view failure as a healthy, inevitable part
of the process of getting to the top.    Joyce Brothers

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5